HealthEquity reported a decrease in revenue by 6% to $188.2 million, but net income increased to $5.4 million. The company's non-GAAP net income was $33.3 million, and it saw growth in HSAs with investments, which increased by 51% year over year.
Revenue decreased by 6% compared to Q4 FY20.
Net income increased compared to a net loss in Q4 FY20.
Non-GAAP net income increased compared to Q4 FY20.
HSAs with investments grew by 51% year over year.
For the fiscal year ending January 31, 2022, HealthEquity expects revenues of $750 million to $760 million, a net loss between $10 million and $5 million, non-GAAP net income between $115 million and $119 million, and Adjusted EBITDA of $240 million to $246 million.
Visualization of income flow from segment revenue to net income